by nhcoa_media | Jan 11, 2024 | Blog
Asthma affects nearly 25 million people in the United States, and 5-10% of these individuals have severe asthma. Of those diagnosed with severe asthma, 50% of people have uncontrolled asthma. Given the statistics, it is important to identify asthma symptoms in order...
by nhcoa_media | Dec 30, 2023 | Cafecito Con NHCOA
En nuestra última edición de año, conversamos con Enrique Jiménez de Latino Alzheimer’s & Memory Disorders Alliance (LAMDA) sobre la concientización del Alzheimer. También conversamos sobre el papel de los cuidadores, las barreras de salud y por qué es...
by nhcoa_media | Dec 20, 2023 | Blog
La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó recientemente varios medicamentos antivirales para tratar el COVID-19, incluyendo el medicamento antiviral Veklury (Remdesivir) para adultos y ciertos pacientes...
by nhcoa_media | Dec 20, 2023 | Blog
Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered...
by nhcoa_media | Dec 14, 2023 | Cafecito Con NHCOA
Discovering the world of COVID-19 treatments raises many questions like: how can one access them? or which treatment might be most effective? In the second part of our two-part special, Dr. Hector Cabrera, Associate Chief Medical Officer for Premier Health, is back to...
Recent Comments